DÄ internationalArchive39/2021Visual phenomena associated with migraine and their differential diagnosis

Review article

Visual phenomena associated with migraine and their differential diagnosis

Dtsch Arztebl Int 2021; 118: 647-53. DOI: 10.3238/arztebl.m2021.0287

Eren, O E; Wilhelm, H; Schankin, C J; Straube, A

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Neurologische Klinik, LMU Klinikum – Campus Großhadern, Ludwig-Maximilians Universität, München: Dr. med. Ozan E. Eren, MD, Prof. Dr. med. Andreas Straube, MD
Neurologische Klinik, Inselspital, Universitätsspital Bern, Universität Bern, Schweiz: Prof. Dr. med. Christoph J. Schankin, MD
Department für Augenheilkunde, Universitäts-Augenklinik Tübingen, Eberhard-Karls Universität, Tübingen: Prof. Dr. med. Helmut Wilhelm, MD
1.Russell MB, Olesen J: A nosographic analysis of the migraine aura in a general population. Brain 1996; 119: 355–61 CrossRef MEDLINE
2.Foroozan R, Cutrer FM: Transient neurologic dysfunction in migraine. Neurol Clin 2019; 37: 673–94 CrossRef MEDLINE
3.Kelman L: The aura: a tertiary care study of 952 migraine patients. Cephalalgia 2004; 24: 728–34 CrossRef MEDLINE
4.Viana M, Tronvik EA, Do TP, Zecca C, Hougaard A: Clinical features of visual migraine aura: a systematic review. J Headache Pain 2019; 20: 64 CrossRef MEDLINE PubMed Central
5.Mastria G, Mancini V, Cesare MD, et al.: Prevalence and characteristics of Alice in Wonderland Syndrome in adult migraineurs: perspectives from a tertiary referral headache unit. Cephalalgia 2021; 41: 515–24 CrossRef MEDLINE
6.Blom JD: Alice in wonderland syndrome. Neurol Clin Pract 2016; 6: 259–70 CrossRef MEDLINE PubMed Central
7.Leao AAP: Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944; 7: 359–90 CrossRef
8.Hadjikhani N, Sanchez del Rio M, Wu O, et al.: Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 2001; 98: 4687–92 CrossRef MEDLINE PubMed Central
9.Lashley KS: Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatry 1941; 46: 331–9 CrossRef
10.Diener HC, Gaul C, Kropp P, et al.: Therapie der Migräneattacke und Prophylaxe der Migräne. S1-Leitlinie. Deutsche Gesellschaft für Neurologie (eds.) 2018. www.dgn.org/leitlinien (last accessed on 28 May 2021).
11.Turk WE, Uiterwijk A, Pasmans R, Meys V, Ayata C, Koehler PJ: Aspirin prophylaxis for migraine with aura: an observational case series. Eur Neurol 2017; 78: 287–9 CrossRef MEDLINE
12.Hauge A, Kirchmann M, Olesen J: Trigger factors in migraine with aura. Cephalalgia 2010; 30: 346–53 CrossRef MEDLINE
13.Lindblad M, Hougaard A, Amin FM, Ashina M: Can migraine aura be provoked experimentally? A systematic review of potential methods for the provocation of migraine aura. Cephalalgia 2017; 37: 74–88 CrossRef MEDLINE
14.Hougaard A, Amin F, Hauge AW, Ashina M, Olesen J: Provocation of migraine with aura using natural trigger factors. Neurology 2013; 80: 428–31 CrossRef MEDLINE
15.Bruyn GW, Weenink HR: Migraine accompagnee, a critical evaluation. Headache J Head Face Pain 1966; 6: 1–22 CrossRef MEDLINE
16.Prabhakaran S, Silver AJ, Warrior L, McClenathan B, Lee VH: Misdiagnosis of transient ischemic attacks in the emergency room. Cerebrovasc Dis 2008; 26: 630–5 CrossRef MEDLINE
17.Tobin WO, Hentz JG, Bobrow BJ, Demaerschalk BM: Identification of stroke mimics in the emergency department setting. J Brain Dis 2009; 1: 19–22 CrossRef MEDLINE PubMed Central
18.Fonseca AC, Merwick Á, Dennis M, et al.: European Stroke Organisation (ESO) guidelines on management of transient ischaemic attack. Eur Stroke J 2021; doi.org/10.1177/2396987321992905 CrossRef MEDLINE PubMed Central
19.Lebedeva ER, Gurary NM, Gilev DV, Christensen AF, Olesen J: Explicit diagnostic criteria for transient ischemic attacks to differentiate it from migraine with aura. Cephalalgia 2018; 38: 1463–70 CrossRef MEDLINE
20.Kokubo Y: Epidemiology of transient ischemic attack. TIA Acute Cerebrovasc Syndr 2014; 33: 69–81 CrossRef MEDLINE
21.Manzoni GC, Torelli P: Epidemiology of migraine. J Headache Pain 2001; 2: s11–3.
22.Hartl E, Angel J, Rémi J, Schankin CJ, Noachtar S: Visual auras in epilepsy and migraine—an analysis of clinical characteristics. Headache J Head Face Pain 2017; 57: 908–16 CrossRef MEDLINE
23.Förderreuther S, Henkel A, Noachtar S, Straube A: Headache associated with epileptic seizures: epidemiology and clinical characteristics. Headache J Head Face Pain 2002; 42: 649–55 CrossRef MEDLINE
24.Forsgren L, Beghi E, Õun A, Sillanpää M: The epidemiology of epilepsy in Europe—a systematic review. Eur J Neurol 2005; 12: 245–53 CrossRef MEDLINE
25.Fischer M, Schmutzhard E: Posterior reversible encephalopathy syndrome. J Neurol 2017; 264: 1608–16 CrossRef MEDLINE PubMed Central
26.Anderson R-C, Patel V, Sheikh-Bahaei N, et al.: Posterior reversible encephalopathy syndrome (PRES): pathophysiology and neuro-imaging. Front Neurol 2020; 11: 463 CrossRef MEDLINE PubMed Central
27.Headache Classification Committee of the International Headache Society (IHS): The international cllassification of headache disorders, 3rd edition. Cephalalgia 2018; 38: 1–211 CrossRef MEDLINE
28.Thissen S, Vos IG, Schreuder TH, Schreurs WMJ, Postma LA, Koehler PJ: Persistent migraine aura: new cases, a literature review, and ideas about pathophysiology. Headache J Head Face Pain 2014; 54: 1290–309 CrossRef MEDLINE
29.Liu GT, Schatz NJ, Galetta SL, Volpe NJ, Skobieranda F, Kosmorsky GS: Persistent positive visual phenomena in migraine. Neurology 1995; 45: 664–8 CrossRef MEDLINE
30.Schankin CJ, Maniyar FH, Digre KB, Goadsby PJ: “Visual snow”—a disorder distinct from persistent migraine aura. Brain 2014; 137: 1419–28 CrossRef MEDLINE
31.Schankin CJ, Maniyar FH, Sprenger T, Chou DE, Eller M, Goadsby PJ: The relation between migraine, typical migraine aura and visual snow (TM). Headache 2014; 54: 957–66 CrossRef MEDLINE
32.Eren O, Rauschel V, Ruscheweyh R, Straube A, Schankin CJ: Evidence of dysfunction in the visual association cortex in visual snow syndrome. Ann Neurol 2018; 84: 946–9 CrossRef MEDLINE
33.Lauschke JL, Plant GT, Fraser CL: Visual snow: a thalamocortical dysrhythmia of the visual pathway? J Clin Neurosci 2016; 28: 123–7.
34.Unal-Cevik I, Yildiz FG: Visual snow in migraine with aura: further characterization by brain imaging, electrophysiology, and treatment—case report. Headache J Head Face Pain 2015; 55: 1436–41 CrossRef MEDLINE
35.Puledda F, Schankin C, Goadsby PJ: Visual snow syndrome. Neurology 2020; 94: e564–74 CrossRef MEDLINE PubMed Central
36.Schankin CJ, Maniyar FH, Chou DE, Eller M, Sprenger T, Goadsby PJ: Structural and functional footprint of visual snow syndrome. Brain 2020; 143: 1106–13 CrossRef MEDLINE PubMed Central
37.Schankin CJ, Viana M, Goadsby PJ: Persistent and repetitive visual disturbances in migraine: a review. Headache 2017; 57: 1–16 CrossRef MEDLINE
38.Eren O, Schankin CJ: Insights into pathophysiology and treatment of visual snow syndrome: a systematic review. Prog Brain Res 2020; 255: 311–26 CrossRef MEDLINE
39.American Psychiatric Association: Diagnostic and statistical manual of mental disorders. 5th edition. American Psychiatric Association 2013. DOI: 10.1176/appi.books.9780890425596 CrossRef
40.Halpern JH, Pope HG: Hallucinogen persisting perception disorder: what do we know after 50 years? Drug Alcohol Depend 2003; 69: 109–19 CrossRef
e1.Martinotti G, Santacroce R, Pettorruso M, et al.: Hallucinogen persisting perception disorder: etiology, clinical features, and therapeutic perspectives. Brain Sci 2018; 8: 47 CrossRef MEDLINE PubMed Central
e2.Eren OE, Schöberl F, Schankin CJ, Straube A: Visual snow syndrome after start of citalopram—novel insights into underlying pathophysiology. Eur J Clin Pharmacol 2021; 77: 271–2 CrossRef MEDLINE PubMed Central
e3.Abbott EJ, Connor GB, Artes PH, Abadi RV: Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet Syndrome). Invest Ophthalmol Vis Sci 2007; 48: 1416–23 CrossRef MEDLINE
e4.Eperjesi F, Akbarali N: Rehabilitation in Charles Bonnet syndrome: a review of treatment options. Clin Exp Optom 2004; 87: 149–52 CrossRef MEDLINE
e5.Subhi Y, Schmidt DC, Bach-Holm D, Kolko M, Singh A: Prevalence of charles bonnet syndrome in patients with glaucoma: a systematic review with meta-analyses. Acta Ophthalmol (Copenh) 2021; 99: 128–33 CrossRef MEDLINE
e6.Teunisse RJ, Zitman FG, Cruysberg JRM, Hoefnagels WHL, Verbeek ALM: Visual hallucinations in psychologically normal people: Charles Bonnet’s syndrome. Lancet 1996; 347: 794–7 CrossRef
e7.Bond-Taylor M, Jakobsson G, Zetterberg M: Posterior vitreous detachment—prevalence of and risk factors for retinal tears. Clin Ophthalmol Auckl NZ 2017; 11: 1689–95 CrossRef MEDLINE PubMed Central
e8.Bechrakis NE, Dimmer A: Rhegmatogene Netzhautablösung. Ophthalmol 2018; 115: 163–78 CrossRef MEDLINE
e9.Kreft D, Doblhammer G, Guthoff RF, Frech S: Prevalence, incidence, and risk factors of primary open-angle glaucoma—a cohort study based on longitudinal data from a German public health insurance. BMC Public Health 2019; 19: 851 CrossRef MEDLINE PubMed Central
e10.Nicolas Feltgen, Bernd Bertram, Daniela Claessens, et al.: S2e-Leitlinie: Retinale arterielle Verschlüsse (RAV). AWMF online. www.awmf.org/uploads/tx_szleitlinien/045-013l_S2e_Retinale_Arterienverschluesse_2017-08.pdf (last accessed on 11 August 2021).
e11.Wilhelm H, Schabet M: The diagnosis and treatment of optic neuritis. Dtsch Arztebl Int 2015; 112: 616–26 CrossRef MEDLINE PubMed Central
e12.Davis FA, Bergen D, Schauf C, McDonald I, Deutsch W: Movement phosphenes in optic neuritis: a new clinical sign. Neurology 1976; 26: 1100–4 CrossRef MEDLINE
e13.Grosberg BM, Solomon S, Lipton RB: Retinal migraine. Curr Pain Headache Rep 2005; 9: 268–71 CrossRef MEDLINE
e14.Hill DL, Daroff RB, Ducros A, Newman NJ, Biousse V: Most cases labeled as “Retinal Migraine” are not migraine. J Neuroophthalmol 2007; 27: 3–8 CrossRef MEDLINE

Info

Article

Specialities